The continuing crisis in antibiotic resistance.

[1]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[2]  J. Otter,et al.  Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. , 2010, The Lancet. Infectious diseases.

[3]  J. Oosterhaven,et al.  Annual Report 2008 , 2009 .

[4]  P. Courvalin,et al.  VanA-Type Vancomycin-Resistant Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.

[5]  P. Nordmann,et al.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.

[6]  K. Laupland,et al.  Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern , 2008 .

[7]  F. Baquero,et al.  Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15 , 2008, Emerging infectious diseases.

[8]  J. Blanco,et al.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.

[9]  J. Otter,et al.  Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat. , 2006, The Lancet. Infectious diseases.

[10]  J. Bartlett.  Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease , 2006, Annals of Internal Medicine.

[11]  Roberta B Carey,et al.  Methicillin-resistant S. aureus infections among patients in the emergency department. , 2006, The New England journal of medicine.

[12]  B. Cookson,et al.  Guidelines for the control of glycopeptide-resistant enterococci in hospitals. , 2006, The Journal of hospital infection.

[13]  Jon Brazier,et al.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.

[14]  G. French.  Clinical impact and relevance of antibiotic resistance. , 2005, Advanced drug delivery reviews.

[15]  F. Baquero,et al.  Global Spread of Vancomycin-resistantEnterococcus faeciumfrom Distinct Nosocomial Genetic Complex , 2005 .

[16]  F. Baquero,et al.  Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex , 2005, Emerging infectious diseases.

[17]  William R Bishai,et al.  Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. , 2005, The Lancet. Infectious diseases.

[18]  Roger Finch,et al.  Lack of development of new antimicrobial drugs: a potential serious threat to public health. , 2005, The Lancet. Infectious diseases.

[19]  M. Kaufmann,et al.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. , 2004, The Journal of antimicrobial chemotherapy.

[20]  J. Powers,et al.  Trends in antimicrobial drug development: implications for the future. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  N. Weightman,et al.  Problems with the decontamination of dental handpieces and other intra-oral dental equipment in hospitals. , 2004, The Journal of hospital infection.

[22]  R. Freeman,et al.  National Clostridium difficile Standards Group: Report to the Department of Health. , 2004, The Journal of hospital infection.

[23]  Nnis System.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.

[24]  C. Walsh,et al.  The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Kuroda,et al.  The emergence and evolution of methicillin-resistant Staphylococcus aureus. , 2001, Trends in microbiology.

[26]  M. Kollef,et al.  Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  D. Thompson,et al.  Historical Yearly Usage of Vancomycin , 1998, Antimicrobial Agents and Chemotherapy.

[28]  F. Tenover,et al.  Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides , 1998, Journal of Clinical Microbiology.

[29]  H. Chambers.  Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications , 1997, Clinical microbiology reviews.

[30]  J. Bates.  Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. , 1997, The Journal of hospital infection.

[31]  F. Tenover,et al.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.

[32]  R. Leclercq,et al.  Resistance to glycopeptides in enterococci. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  I. Phillips,et al.  Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli , 1995, Antimicrobial agents and chemotherapy.

[34]  C. Kunin,et al.  Resistance to Antimicrobial DrugsA Worldwide Calamity , 1993, Annals of Internal Medicine.

[35]  I. Phillips,et al.  β-Lactamases and susceptibility to β-lactam antibiotics in Escherickia coil , 1992 .

[36]  Mitchell L. Cohen.  Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era , 1992, Science.

[37]  H. Neu,et al.  The Crisis in Antibiotic Resistance , 1992, Science.

[38]  W. Noble,et al.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. , 1992, FEMS microbiology letters.

[39]  J. Hamilton-miller,et al.  Methicillin-resistant Staphylococcus aureus. , 1989, The New England journal of medicine.

[40]  R. Marples.  Antibiotic resistance in Staphylococcus aureus , 1989, The Medical journal of Australia.

[41]  Robert Fritz,et al.  The Path of Least Resistance , 1986 .

[42]  J. Mcgowan,et al.  Antimicrobial resistance in hospital organisms and its relation to antibiotic use. , 1983, Reviews of infectious diseases.

[43]  D. Shanson.  Antibiotic-resistant Staphylococcus aureus. , 1981, The Journal of hospital infection.

[44]  M. Finland,et al.  Occurrence of serious bacterial infections since introduction of antibacterial agents. , 1959, Journal of the American Medical Association.

[45]  A. Fleming,et al.  On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ , 1929 .